Literature DB >> 11775061

The ocular albinism type 1 gene product is an N-glycoprotein but glycosylation is not required for its subcellular distribution.

B Shen1, S J Orlow.   

Abstract

The ocular albinism type 1 (OA1) gene product is a membrane glycoprotein that may play a role in controlling melanosome growth and maturation. A number of mutations in the OA1 gene lead to ocular albinism due at least in part to retention of the aberrant protein in the endoplasmic reticulum. To examine whether N-glycosylation plays a role in the post-translational trafficking of the Oa1 protein, we constructed a series of mutant mouse Oa1 cDNAs encoding an Oa1-green fluorescent protein fusion in which some or all of the potential glycosylation sites were eliminated by site-directed mutagenesis. Biochemical studies in transfected cells treated with tunicamycin and peptide:N-glycosidase F suggest that asparagine at amino acid 106 is essential for N-glycosylation of the protein. Mutation at amino acid 106 that eliminated glycosylation did not affect the endo/lysosomal distribution of the Oa1 protein in either COS cells or cultured murine melanocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11775061     DOI: 10.1034/j.1600-0749.2001.140609.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  7 in total

1.  An unconventional dileucine-based motif and a novel cytosolic motif are required for the lysosomal and melanosomal targeting of OA1.

Authors:  Rosanna Piccirillo; Ilaria Palmisano; Giulio Innamorati; Paola Bagnato; Domenico Altimare; Maria Vittoria Schiaffino
Journal:  J Cell Sci       Date:  2006-04-18       Impact factor: 5.285

Review 2.  Signaling pathways in melanosome biogenesis and pathology.

Authors:  Maria Vittoria Schiaffino
Journal:  Int J Biochem Cell Biol       Date:  2010-04-08       Impact factor: 5.085

3.  The ocular albinism type 1 gene product, OA1, spans intracellular membranes 7 times.

Authors:  Michio Sone; Seth J Orlow
Journal:  Exp Eye Res       Date:  2007-08-29       Impact factor: 3.467

4.  Identification of a novel GPR143 mutation in a large Chinese family with congenital nystagmus as the most prominent and consistent manifestation.

Authors:  Jing Yu Liu; Xiang Ren; Xiufeng Yang; Tangying Guo; Qi Yao; Lin Li; Xiaohua Dai; Mingchang Zhang; Lejin Wang; Mugen Liu; Qing K Wang
Journal:  J Hum Genet       Date:  2007-05-22       Impact factor: 3.172

5.  Novel GPR143 mutations and clinical characteristics in six Chinese families with X-linked ocular albinism.

Authors:  Shaohua Fang; Xiangming Guo; Xiaoyun Jia; Xueshan Xiao; Shiqiang Li; Qingjiong Zhang
Journal:  Mol Vis       Date:  2008-10-30       Impact factor: 2.367

6.  Identification of three novel OA1 gene mutations identified in three families misdiagnosed with congenital nystagmus and carrier status determination by real-time quantitative PCR assay.

Authors:  Valérie Faugère; Sylvie Tuffery-Giraud; Christian Hamel; Mireille Claustres
Journal:  BMC Genet       Date:  2003-01-07       Impact factor: 2.797

7.  L-DOPA is an endogenous ligand for OA1.

Authors:  Vanessa M Lopez; Christina L Decatur; W Daniel Stamer; Ronald M Lynch; Brian S McKay
Journal:  PLoS Biol       Date:  2008-09-30       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.